All > Alcohol > Cardiovascular

Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM) for Alcohol Abuse

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Alcohol Abuse+2 MoreAlcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM) - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a cognitive-behavioral intervention for Veterans with comorbid alcohol misuse and cardiovascular disease risk. The intervention includes telehealth CBT for alcohol misuse, tailored and timely text messages, and a telehealth coaching call. The primary hypotheses are that the intervention will be feasible, acceptable, and show signs of reducing alcohol misuse and increasing behaviors associated with cardiovascular health.

Eligible Conditions
  • Alcohol Abuse
  • High Blood Pressure

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
mHealth parenting stress app
2
Text Messaging + Health Navigation (TM+HN)
3
Evolocumab + Routine Lipid Management

Study Objectives

5 Primary · 3 Secondary · Reporting Duration: 6 months Post-Baseline

10 Weeks Post-Baseline
SMS Text Acceptability
Treatment Acceptability
Treatment Feasibility
6 Weeks Post-Baseline
Therapist Fidelity
6 months Post-Baseline
Past-Month Self-Reported Heavy Drinking Days
ReComp Pharmacy Refill Compliance Estimate for CVD medications
Systolic Blood Pressure
Baseline Only
Enrollment Feasibility

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
mHealth parenting stress app
3
Text Messaging + Health Navigation (TM+HN)
3
Evolocumab + Routine Lipid Management

Trial Design

1 Treatment Group

ACME-TM
1 of 1

Experimental Treatment

40 Total Participants · 1 Treatment Group

Primary Treatment: Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM) · No Placebo Group · N/A

ACME-TM
Behavioral
Experimental Group · 1 Intervention: Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months post-baseline

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,485 Previous Clinical Trials
2,742,179 Total Patients Enrolled
2 Trials studying Alcohol Abuse
204 Patients Enrolled for Alcohol Abuse
Daniel Blalock, PhDPrincipal InvestigatorDurham VA Medical Center, Durham, NC

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are enrolled in one of three primary care clinics associated with the Durham VAHCS.
You are currently prescribed at least one oral medication for hypertension, hyperlipidemia, and/or diabetes mellitus as evidenced by at least one pharmacy refill within the previous year.
You have access to a mobile phone with SMS capabilities.
Appropriate medication regimen for CVD prevention, screened by research coordinator and reviewed by Matt Crowley, MD (Mentor).
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top